| # | Drug | Count |
|---|---|---|
| 0 | CERTOLIZUMAB PEGOL | 3 |
| 1 | ACETAMINOPHEN | 1 |
| 2 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 1 |
| 3 | C1 ESTERASE INHIBITOR RECOMBINANT | 1 |
| 4 | DUPILUMAB | 1 |
| 5 | EPTINEZUMAB-JJMR | 1 |
| 6 | IBUPROFEN | 1 |
| 7 | IBUPROFEN SODIUM | 1 |
| 8 | IBUPROFEN TABLETS, COATED | 1 |
| 9 | IRON | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | UBLITUXIMAB | 1 | 0.0003 |
| 1 | C1 ESTERASE INHIBITOR RECOMBINANT | 1 | 0.0002 |
| 2 | EPTINEZUMAB-JJMR | 1 | 0.0001 |
| 3 | TOLVAPTAN | 1 | 0.0001 |
| 4 | IBUPROFEN SODIUM | 1 | 0.0000 |
| 5 | IRON | 1 | 0.0000 |
| 6 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0000 |
| 7 | IBUPROFEN | 1 | 0.0000 |
| 8 | ACETAMINOPHEN | 1 | 0.0000 |
| 9 | PREDNISONE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |
| 1 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 2 | Expectorant [EPC] | 1 | 0.0000 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 3 | 0.0000 |
| 5 | Interleukin-4 Receptor alpha Antagonist [EPC] | 1 | 0.0000 |
| 6 | Corticosteroid [EPC] | 1 | 0.0000 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |